{
  "ptid_time": "123_S_0106_2013-02-05",
  "img_path": "/data/qiuhui/data/adni/images/123_S_0106/2013-02-05/t1.nii.gz",
  "img_finding": "",
  "text_data": "Age is 80.2 years. Gender is Female. Education: 15 years. Handedness: Unknown. Race: Unknown. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Malignancy. MMSE: 26.0. MoCA: 20.0. Logical Memory: 7.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.28 SUVR (moderate elevated); Amyloid beta: 627.40 pg/mL (mild reduced); Total tau: 308.90 pg/mL (normal ); Phosphorylated tau: 30.99 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The patient shows mild cognitive impairment based on MoCA score (20/30), which is below the typical cutoff for normal cognition (≥26). The MMSE score (26/30) is borderline but still within normal range. Biomarkers indicate moderate amyloid deposition (elevated AV45 and mildly reduced Aβ) and mild tau pathology (mildly elevated P-tau), which is suggestive of early Alzheimer's pathology.  \n\nDiagnosis: MCI (likely due to Alzheimer's disease)  \nConfidence: Medium (cognitive scores are borderline, but biomarker profile supports early AD pathology)",
  "timestamp": "2025-07-26T12:24:06.852529"
}